1. Home
  2. SRPT vs WT Comparison

SRPT vs WT Comparison

Compare SRPT & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • WT
  • Stock Information
  • Founded
  • SRPT 1980
  • WT 1985
  • Country
  • SRPT United States
  • WT United States
  • Employees
  • SRPT N/A
  • WT N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • WT Investment Bankers/Brokers/Service
  • Sector
  • SRPT Health Care
  • WT Finance
  • Exchange
  • SRPT Nasdaq
  • WT Nasdaq
  • Market Cap
  • SRPT 2.0B
  • WT 2.0B
  • IPO Year
  • SRPT 1997
  • WT N/A
  • Fundamental
  • Price
  • SRPT $18.52
  • WT $14.47
  • Analyst Decision
  • SRPT Hold
  • WT Buy
  • Analyst Count
  • SRPT 31
  • WT 5
  • Target Price
  • SRPT $40.61
  • WT $12.78
  • AVG Volume (30 Days)
  • SRPT 7.8M
  • WT 2.7M
  • Earning Date
  • SRPT 11-05-2025
  • WT 10-24-2025
  • Dividend Yield
  • SRPT N/A
  • WT 0.83%
  • EPS Growth
  • SRPT N/A
  • WT N/A
  • EPS
  • SRPT N/A
  • WT 0.40
  • Revenue
  • SRPT $2,481,531,000.00
  • WT $444,568,000.00
  • Revenue This Year
  • SRPT $10.78
  • WT $12.45
  • Revenue Next Year
  • SRPT N/A
  • WT $11.96
  • P/E Ratio
  • SRPT N/A
  • WT $35.70
  • Revenue Growth
  • SRPT 64.89
  • WT 15.43
  • 52 Week Low
  • SRPT $10.42
  • WT $7.47
  • 52 Week High
  • SRPT $138.81
  • WT $14.45
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 51.43
  • WT 66.11
  • Support Level
  • SRPT $17.05
  • WT $13.70
  • Resistance Level
  • SRPT $18.84
  • WT $14.40
  • Average True Range (ATR)
  • SRPT 1.02
  • WT 0.37
  • MACD
  • SRPT -0.01
  • WT 0.03
  • Stochastic Oscillator
  • SRPT 60.51
  • WT 100.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.

Share on Social Networks: